Ontology highlight
ABSTRACT:
SUBMITTER: Zeidan AM
PROVIDER: S-EPMC4775363 | biostudies-literature | 2016 Mar
REPOSITORIES: biostudies-literature
Zeidan A M AM Sekeres M A MA Garcia-Manero G G Steensma D P DP Zell K K Barnard J J Ali N A NA Zimmerman C C Roboz G G DeZern A A Nazha A A Jabbour E E Kantarjian H H Gore S D SD Maciejewski J P JP List A A Komrokji R R
Leukemia 20151014 3
Established prognostic tools in patients with myelodysplastic syndromes (MDS) were largely derived from untreated patient cohorts. Although azanucleosides are standard therapies for higher-risk (HR)-MDS, the relative prognostic performance of existing prognostic tools among patients with HR-MDS receiving azanucleoside therapy is unknown. In the MDS Clinical Research Consortium database, we compared the prognostic utility of the International Prognostic Scoring System (IPSS), revised IPSS (IPSS-R ...[more]